Results 121 to 130 of about 102,448 (289)

Epidemiology and Genetics of Rheumatic Diseases Suggest a Constant Rate of DNA Damage as Underlying Cause

Immunology, EarlyView.
A constant rate of DNA damage that is not perfectly repaired will cause a constant rate of DNA mutations. The chance of mutation will increase if DNA is prone to damage, such as occurs in somatic hypermutation (SHM) hotspots and GC‐rich DNA. Thus, if one mutation‐prone DNA site drives disease, the age of onset of disease and degree of penetrance should
Piet C. de Groen
wiley   +1 more source

Quality of life in patients with Ankylosing Spondylitis in Duhok government, Kurdistan of Iraq

Advanced Medical Journal
Background and objectives: Spondylarthritis is a broad spectrum of chronic inflammatory diseases, and one of its of phenotypes is ankylosing spondylitis.
Nahida Zuber Ali, Muhammed Tahir Rasool   +1 more
doaj   +1 more source

Quantification of paravertebral cross-sectional muscle areas and fatty degeneration and their correlation with clinical parameters in ankylosing spondylitis: a comprehensive analysis [PDF]

ARP Rheumatology
Aims: Ankylosing spondylitis (AS) is a chronic disease characterized by inflammation of the spine and joints. This study aimed to examine the multifidus (MF) and erector spinae (ES) muscles in AS patients using magnetic resonance imaging (MRI), and to ...
Selçuk Akkaya, Gonca Sağlam Akkaya, Serpil Demirulus, Hanife Baykal Şahin, Gamze Kılıç, Erhan Çapkın, Murat Karkucak   +6 more
doaj  

Efficacy and Safety Of Radiation Synovectomy with Yttrium-90 [PDF]

, 1993
In this long term retrospective study of radiation synovectomy with Yttrium-90 (Y90), we evaluated the results of 164 applications in 82 patients with RA, OA with synovitis, ankylosing spondylitis and psoriatic arthritis.
Bozzone, P., Felder, M., Stucki, Gerold, Treuer, E., Wassmer, P.   +4 more
core  

Aetiology of Ankylosing Spondylitis [PDF]

, 1949
H. F. West
openalex   +1 more source

Efficacy and safety of brodalumab in palmoplantar pustulosis: A 68‐week randomized Phase 3 trial

Journal of the European Academy of Dermatology and Venereology, EarlyView.
This open‐label study is a continuation of the 16‐week double‐blind, Phase 3 trial assessing the efficacy and safety of brodalumab 210 mg subcutaneously, till a 68‐week extension period. Continued improvement was seen in the PPPASI 50/75/90 responses, PPPSI scores, PGA 0/1 responses and DLQI. Abstract Background The efficacy and safety of brodalumab in
Masamoto Murakami, Yukari Okubo, Satomi Kobayashi, Natsuko Kikuta, Yoshiumi Ouchi, Kenta Shishido, Tadashi Terui   +6 more
wiley   +1 more source

Causal relationship between gut microbiota and ankylosing spondylitis and potential mediating role of inflammatory cytokines: A mendelian randomization study.

PLoS ONE
Associations between gut microbiota and ankylosing spondylitis have been discovered in previous studies, but whether these associations reflect a causal relationship remains inconclusive. Aiming to reveal the bidirectional causal associations between gut
Xinyu Du, Haibo Li, Hongzhou Zhao, Shuangshuang Cui, Xiaozhuo Sun, Xiaochan Tan   +5 more
doaj   +1 more source

Does Tooth Position Change Between Preparation and Cementation in Overlay Restoration? A Clinical Evaluation With/Out Interappointment Provisionalization

Journal of Esthetic and Restorative Dentistry, EarlyView.
ABSTRACT Objective To evaluate whether teeth prepared for overlay restoration, as well as their antagonist or adjacent teeth, undergo positional changes between tooth preparation and final cementation appointments, with or without the use of a temporary restoration.
Del Bianco Federico, Mancuso Edoardo, Mazzitelli Claudia, Maravic Tatjana, Mazzoni Annalisa, Breschi Lorenzo   +5 more
wiley   +1 more source

Introduction. Ankylosing spondylitis [PDF]

Neurosurgical Focus, 2021
Doniel, Drazin, J Patrick, Johnson, Tiffany, Perry, Michael Y, Wang, Jens R, Chapman, Bernhard, Meyer   +5 more
openaire   +2 more sources

Withdrawn: Impact of the RNF123 mutation on osteoclast differentiation in familial ankylosing spondylitis

Rheumatology &Autoimmunity, EarlyView.
Jin S, Ji X, Zhang L, Shi Y, Zhao D, Wan W. Impact of the RNF123 mutation on osteoclast differentiation in familial ankylosing spondylitis. Rheumatol & Autoimmun. 2023;1‐8. doi:10.1002/rai2.12102 Withdrawal: The above article, first published online 11th September 2024, on Wiley Online Library (wileyonlinelibrary.com), has been withdrawn by agreement ...
wiley   +1 more source